- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
PML Antibody / Promyelocytic Leukemia Protein Polyclonal Antibody targets promyelocytic leukemia protein (PML), also known as TRIM19, a member of the tripartite motif family involved in nuclear organization, transcriptional regulation, and cellular stress responses. PML functions as a tumor suppressor and is best known for its role in organizing PML nuclear bodies, dynamic nuclear structures that recruit numerous regulatory proteins. These structures participate in processes including apoptosis, senescence, DNA damage responses, and antiviral defense. PML contains a conserved RBCC motif comprising a RING finger domain, two B-box domains, and a coiled-coil region that contributes to protein interactions and nuclear body assembly.
PML nuclear bodies serve as organizational platforms for proteins involved in transcriptional control, genome maintenance, and cellular stress signaling. Their formation depends on PML oligomerization and post-translational modifications, particularly SUMOylation. SUMO modification promotes interactions with proteins containing SUMO-interacting motifs and contributes to the recruitment and retention of nuclear body components. PML also undergoes phosphorylation, ubiquitination, and other regulatory modifications that influence its stability, localization, and interactions. Alternative splicing generates multiple PML isoforms with distinct C-terminal sequences, contributing to differences in subcellular distribution and biological function.
PML has an important role in regulating the p53 tumor suppressor pathway and cellular responses to oncogenic stress. Through interactions with transcriptional regulators and signaling proteins, PML contributes to cell cycle control, apoptosis, and senescence. Its nuclear bodies also participate in DNA damage signaling and the regulation of chromatin-associated processes. PML expression and nuclear body organization can change in response to interferon signaling, viral infection, oxidative stress, and other cellular challenges. These properties connect PML to both intrinsic tumor suppression and broader mechanisms of cellular defense.
The PML gene is prominently associated with acute promyelocytic leukemia, in which a chromosomal translocation produces the PML-RARA fusion protein. This oncogenic fusion disrupts normal PML nuclear body organization and alters retinoic acid-dependent transcriptional regulation. Therapeutic degradation of PML-RARA allows restoration of normal nuclear structures and contributes to leukemia cell differentiation. Beyond leukemia, altered PML expression and function have been investigated in solid tumors, metabolic regulation, and cellular aging. PML Antibody supports research into nuclear body organization, tumor suppressor signaling, and the molecular mechanisms linking PML dysfunction to cancer and other diseases.
PML is an important tumor suppressor associated with nuclear body organization, cellular stress responses, and acute promyelocytic leukemia, making it a significant target in cancer research.
Differences in protocols and secondary/substrate sensitivity may require the PML Antibody / Promyelocytic Leukemia Protein Polyclonal Antibody to be titrated for optimal performance.
Amino acids 141-179 (FECEQLLCAKCFEAHQWFLKHEARPLAELRNQSVREFLD) from the human protein were used as the immunogen for the PML antibody.
After reconstitution, the PML antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
TRIM19 antibody, Promyelocytic leukemia protein antibody, Protein PML antibody, Tripartite motif-containing protein 19 antibody, Promyelocytic leukemia nuclear body protein antibody, PML nuclear body protein antibody, PML tumor suppressor antibody, RING finger protein PML antibody, Promyelocytic leukemia zinc finger protein antibody, PML protein antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.